Skip to main content
OpenTrials
Completed

NCT Number: NCT04216056

Evaluation of a Frailty Intervention Program in Hong Kong

The present study aims to compare the pre-post effect of a frailty intervention program with exercise, nutrition, cognitive and social components with a control group without such program on improving gait speed and frailty in community-dwelling Chinese adults aged 50 and above who are pre-frail or frail using the FRAIL scale, and to obtain their views towards the frailty intervention program. The investigators hypothesized that the frailty intervention program will result in improvements regarding frailty, mobility, weight status and other health outcomes.

This study will be a non-randomized controlled study using a controlled before-and-after study design. Eligible subjects will be assigned to one of the two groups: frailty intervention program, or control group without any intervention, over 12 weeks. A total of 152 subjects (76 per group) will be recruited. A sub-sample of 25 subjects from the intervention group will be invited to share their experience and opinion in focus groups.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chinese University of Hong Kong

Hong Kong, China

About this study

A 30-month trial, which will be divided into three phases, namely study preparation and subject recruitment (6 months), data collection (18 months), and data entry and analysis (6 months), will be conducted.

This study will be a non-randomized controlled study using a controlled before-and-after study design. Eligible subjects will receive a baseline assessment in the community facilities. After that, eligible subjects will be assigned to one of the two groups: frailty intervention program, or control group without any intervention, over 12 weeks. Subjects in the frailty intervention program will be invited to participate in the following components: exercise, game training and nutrition education; while subjects in the control group will be asked to maintain their usual diet and physical activity patterns. A total of 152 subjects (76 per group) will be recruited. Outcome measurements will be collected at two time points, namely baseline (T0), and 12 (T1) weeks.

The primary outcome will be the improvement in gait speed over 12 weeks. Secondary outcomes will include the change in the following parameters over 12 weeks: frailty, handgrip strength, 5 chair stands, balance test, Frontal Assessment Battery, dietary intake, nutritional status, physical activity, self-rated health, life satisfaction and self-efficacy of chronic disease management. In a sub-sample of 25 subjects from the intervention group, their views towards the frailty intervention program will be obtained from the focus group study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People aged 50 years or older;
  • FRAIL score ≥ 1, and thus are considered pre-frail / frail;
  • Chinese origin;
  • Normally reside in Hong Kong;
  • Could speak and understand Chinese;
  • Willing to follow the study procedures.

Exclusion criteria

  • Live in a residential aged care facility;
  • Recent (i.e. past 3 months) or concurrent participation in any clinical trial or exercise and/or cognitive and/or dietary intervention program;
  • With medical advice or conditions prohibiting exercise or medical conditions that precluded safe participation in an exercise program;
  • With any other indication of a major medical or psychological illness, as judged by the investigators as ineligible to participate the study.

Treatment and study plan

Frailty intervention program

Behavioral

There will be 2 sessions per week for 12 weeks. Each session includes 1 hour exercise (including 5-10 minute warm-up and cool-down routine, 20-30 minute chair-based resistance exercises using Thera-Bands for muscle groups in both the upper and lower body, and 20-30 minutes aerobic exercises); and 1 hour game training using computer video games, board games and card games. Nutrition education will be given to the subjects based on their weight status. The 1st level of nutrition information (healthy eating tips for frailty prevention and management) will be given to all subjects on regular basis during the 12-week study period via short videos, text messages or Whatsapp reminders. On top of the 1st level nutrition information, 3 nutrition heath talks (1-1.5 hours per talk) about weight management will be given to those with BMI >=25 kg/m2, and/or waist circumference >=90 cm (male) or >=80 cm (female) during the 12-week study period.

Primary outcomes

  1. Change in gait speed

    Time frame: baseline, 12 weeks

    This outcome will be measured using the 6-meter walk test.

Secondary outcomes

  1. Frailty status

    Time frame: baseline, 12 weeks

    Frailty status (i.e. robust, prefrail or frail) measured using the frailty scale (FRAIL) in which unabbreviated scale name is unavailable for this scale. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.

  2. Handgrip strength

    Time frame: baseline, 12 weeks

    Handgrip strength will be measured using a dynamometer.

  3. 5 chair stands

    Time frame: baseline, 12 weeks

    Muscle endurance in the lower extremities - Participant will be required to rise from a chair a total of 5 times, as quickly as they could, with arms across their chest. The amount of time required to complete all 5 repetitions will be recorded.

  4. Balance test

    Time frame: baseline, 12 weeks

    Participant will be required to stand with different postures and maintain balance for 10 seconds each. The number of completed posture will be used for analysis.

  5. Cognitive performance

    Time frame: baseline, 12 weeks

    Frontal Assessment Battery will be used to assess executive function. Total score is a maximum of 18, higher scores indicating better performance.

  6. Dietary intake

    Time frame: baseline, 12 weeks

    Dietary habits and patterns over the past week will be assessed using a questionnaire designed by the research team based on the questionnaire used in the Hong Kong Child Health Survey (Department of Health, 2009) with modifications.

  7. Nutritional status

    Time frame: baseline, 12 weeks

    This outcome will be assessed using Mini-Nutritional Assessment Short Form (MNA-SF). The total score of the MNA-SF ranges from 0-14 points, with 0-7 points indicate malnourished, 8-11 points as at risk of malnutrition and 12-14 points as normal nutritional status.

  8. Physical activity

    Time frame: baseline, 12 weeks

    This outcome will be assessed using a validated Chinese version of the International Physical Activity Questionnaire (IPAQ-C). Metabolic equivalent for Task (MET)-minutes/week values for walking, moderate-intensity activities, vigorous-intensity activities, and total physical activities will be calculated for data analysis. Higher MET-minutes/week value represents higher amount of energy expended in carrying out physical activity.

  9. Self-rated health

    Time frame: baseline, 12 weeks

    This outcome will be elicited by a single question, "Generally speaking, how is your health: excellent, very good, good, fair, or poor?" .

  10. Life satisfaction

    Time frame: baseline, 12 weeks

    This outcome will be assessed by the subjects' response to the question "Are you satisfied with life?", using a 0 to 10-point linear scale. Higher point represents better self-rated life satisfaction.

  11. Self-efficacy of chronic disease management

    Time frame: baseline, 12 weeks

    This outcome will be assessed using a validated Chinese version of short-form Chronic Disease Self-Efficacy Scales (CDSES) for older adults. Each item will be rated by the subjects on a scale from 1-10. The total score of the short-form CDSES is the mean of the six items, with higher score indicates better self-efficacy.

  12. Views towards the frailty intervention program

    Time frame: 12 weeks

    Participants in the intervention group will be invited to share their experience and opinion in focus groups (of 1 to 1.5 hours duration).

Other outcomes

  1. Weight

    Time frame: baseline, 12 weeks

    Weight in kilogram measured using standardized method.

  2. Height

    Time frame: baseline, 12 weeks

    Height in centimeter measured using standardized method.

  3. Waist circumference

    Time frame: baseline, 12 weeks

    Waist circumference in centimeter measured using standardized method.

  4. Systolic blood pressure

    Time frame: baseline, 12 weeks

    Systolic blood pressure in mmHg measured using standardized method.

  5. Diastolic blood pressure

    Time frame: baseline, 12 weeks

    Diastolic blood pressure in mmHg measured using standardized method.

  6. Fat mass percentage

    Time frame: baseline, 12 weeks

    This outcome will be measured using bioelectrical impedance analysis (BIA).

  7. Fat free mass percentage

    Time frame: baseline, 12 weeks

    This outcome will be measured using bioelectrical impedance analysis (BIA).

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

Evaluation of a Frailty Intervention Program in Hong Kong: A Pre-Post Study and a Focus Group Study

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jan 2, 2020
Registry last updated
May 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.